Monosomy 7 Myelodysplasia And Leukemia Syndrome 1 C1854978
A genetic predisposition to bone marrow disorders that may progress to myelodysplastic syndrome or leukemia. Regular blood monitoring is essential. Treatment may include chemotherapy or stem cell transplant.
Key facts at a glance
- ICD-10
- D64.9
- ICD-11
- 3A00.0
- Body system
- hematologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Fatigue
(hematologic)Generalized symptoms
(hematologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Easy bruising
(hematologic)Recurrent infections
(immune)Bone pain
(musculoskeletal)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Allogeneic Hematopoietic Stem Cell Transplantation
Curative approach using donor stem cells to replace dysfunctional bone marrow. Pre-transplant conditioning chemotherapy is required followed by engraftment monitoring.
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
Frequent Hematologic Surveillance
Regular monitoring of complete blood counts, bone marrow biopsies, and cytogenetic studies to track disease progression and treatment response in myelodysplasia.
Additional treatment options
Hypomethylating Agent Therapy
DNA methyltransferase inhibitors such as azacitidine or decitabine to modify disease progression in myelodysplastic syndrome associated with monosomy 7.
medicationSupportive Transfusion Therapy
Red blood cell and platelet transfusions to manage cytopenias and prevent complications from anemia or bleeding in advanced myelodysplasia.
medicationInfection Prevention Protocol
Implementation of rigorous hygiene practices, vaccination optimization, and avoidance strategies to prevent infections given immunocompromised state.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Monosomy 7 Myelodysplasia And Leukemia Syndrome 1 C1854978?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Monosomy 7 Myelodysplasia And Leukemia Syndrome 1 C1854978. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy